CDK2 and neuroblastoma: Our data also indicate that the use of specific inhibitors such as ICA-1S and ζ-Stat not only decreases the survival of NB cells by downregulating Akt1/NFκB signaling, but also adversely affects cell cycle progression by down-regulating Cdk7/Cdk2/aPKC pathway.